$0.1949
-0.004-2.01%
Last update: Oct 29, 7:51 PM
TScan Therapeutics Inc (TCRX) Stock Price, Quote, News & History
TCRXNASDAQ
U.S. stocks rose mid-session, led by materials; factory orders beat estimates. Linkhome, Purple Biotech and GitLab surged, while Tscan and Credo fell.
You can purchase shares of TScan Therapeutics (NASDAQ:TCRX) through any online brokerage.
Other companies in TScan Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
TScan Therapeutics has a consensus price target of $6.67.
The stock price for TScan Therapeutics (NASDAQ: TCRX) is $0.197 last updated October 29, 2026 at 7:51 PM EDT.
There are no upcoming dividends for TScan Therapeutics.
TScan Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for TScan Therapeutics.
TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid...
